By Michael Erman and Christy Santhosh Jan 20 (Reuters) - Novavax said on Tuesday it signed a licensing agreement allowing ...
Under the terms of the agreement, Pfizer is expected to pay an upfront total of $30 million in early 2026 to Novavax, while ...
Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine ...
A research team led by Professor Chen Peng from the College of Chemistry and Molecular Engineering at Peking University has ...
Accelerated by the COVID-19 pandemic, research is now exploring vaccines capable not only of preventing infections, but also ...
Hosted on MSN
Development of a new tuberculosis vaccine and treatment platform...More than 90% inhibition of tuber...
A new strategy has been developed to prevent and treat tuberculosis using antigen-presenting cells. Professor Shin Sung-jae and Dr. Kim Hong-min's research team at Yonsei University Medical School ...
Health and Human Services Secretary Robert F. Kennedy Jr. is targeting the government’s Vaccine Injury Compensation Program, without which manufacturers might cease producing shots. (Eric ...
Invivyd, Inc. has submitted a Citizen Petition to the FDA advocating for a new approach to the development of COVID-19 vaccines and monoclonal antibodies (mAbs) to restore public trust in health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results